Immune Cell Activation Readouts

About illumicell AI

illumicell AI is an early-stage, AI-driven diagnostics company operating out of the Harvard Pagliuca Life Lab. The company has developed a proprietary technology platform that uses AI to analyze cellular behavior, generating significantly more data than standard tests. Its initial focus areas are AI-powered semen analysis for fertility and immune cell activation readouts for immuno-oncology and autoimmune disease monitoring. The company raised a $2M pre-seed round in 2025 and is collaborating with Harvard on research studies.

Therapeutic Areas